TAUNS Laboratories,Inc. (TYO:197A)

TAUNS Laboratories,Inc. Balance Sheet

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023
Cash & Equivalents	8,581	9,425	1,244
Cash & Short-Term Investments	8,581	9,425	1,244
Cash Growth	-	657.40%	-
Accounts Receivable	4,975	2,707	3,051
Other Receivables	-	16.41	429.41
Receivables	4,975	2,723	3,481
Inventory	5,014	4,717	4,587
Prepaid Expenses	-	30.78	19.12
Other Current Assets	183.55	19.32	125.83
Total Current Assets	18,754	16,916	9,457
Property, Plant & Equipment	12,152	7,905	4,402
Long-Term Investments	2,864	686.51	487.69
Other Intangible Assets	3,866	3,721	3,910
Other Long-Term Assets	0	33.01	75.29
Total Assets	37,635	29,261	18,332
Accounts Payable	1,297	1,483	1,143
Accrued Expenses	230.6	1,010	267.98
Short-Term Debt	4,500	4,500	3,500
Current Portion of Long-Term Debt	832	732	732
Current Income Taxes Payable	1,547	1,706	-
Other Current Liabilities	2,443	1,044	874.56
Total Current Liabilities	10,850	10,474	6,518
Long-Term Debt	8,300	4,307	2,236
Long-Term Deferred Tax Liabilities	620.23	619.49	922.12
Other Long-Term Liabilities	12	12	12
Total Liabilities	19,963	15,595	9,842
Common Stock	271.73	200	100
Additional Paid-In Capital	2,755	2,683	2,783
Retained Earnings	14,638	10,778	5,604
Comprehensive Income & Other	7.65	5.61	2.81
Shareholders' Equity	17,672	13,667	8,490
Total Liabilities & Equity	37,635	29,261	18,332
Total Debt	13,632	9,539	6,468
Net Cash (Debt)	-5,051	-114.11	-5,224
Net Cash Per Share	-44.80	-1.07	-52.24
Filing Date Shares Outstanding	102.39	100	100
Total Common Shares Outstanding	102.39	100	100
Working Capital	7,904	6,441	2,939
Book Value Per Share	172.59	136.67	84.90
Tangible Book Value	13,806	9,946	4,580
Tangible Book Value Per Share	134.84	99.46	45.80
Land	-	1,735	1,735
Buildings	-	1,110	1,036
Machinery	-	2,729	2,511
Construction In Progress	-	3,973	497.14

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.